To carry out this study, it is pointed out how, with the use of high-power TECARTHERAPY devices, an electric field is generated in the tissue, causing the molecular movement of charged particles. All this set allows the generation of heat. Through the use of temperatures ranging between 40 and 45 °C, TECAR THERAPY induces fibroblasts to produce collagen, and in addition, heat shock proteins are activated and the start of the inflammatory cascade is generated. On the other hand, they release protons and electrons that block the Na+/Ka+ ATPase.It is known that exposure to RF induced differential proinflammatory responses in astrocytes and microglia, characterized by different profiles of expression and release of IL-1β, TNF-α, IL-6, PGE2, nitric oxide (NO), inducible nitric oxide synthase ( iNOS) and cyclooxygenase 2 (COX2

We have used minimally invasive convective radiofrequency (RF) therapy.  Radiofrequency devices emit electromagnetic waves that heat the underlying tissues without affecting the melanin. The release of thermal energy induces collagen contraction, neocollagenesis, and neovascularization, all of which help restore the elasticity and moisture of the vaginal mucosa . Devices can also be equipped with cooling sensors and heating regulators to protect the mucosal surface while heating deeper tissues The MJS intracavitary capacitance electrode and the active plate were applied simultaneously. Four studies are presented that support the goodness of the treatment. 30 patients, 10 men up to 65 years old with post-radical prostatectomy urinary incontinence. 11 women with an average age of 54.8 years who presented vaginal laxity and dryness and persistent pain during sexual intercourse. 10 women, average age 57.5 years with sexual dysfunction. 53 women with endometriosis pain

With 80%. Changes were found in the pain and strength variables, from 5.90 ± 3.98 to 1.30 ± 2.54, p = 0.002 and from 3.30 ± 1.49 to 4.80 ± 0.42, p = 0.005. 100% improves sexual satisfaction. And from 1.90 ± 0.99 to 4.10 ± 0.56, p = 0.000 for vaginal dryness and from 2.17 ± 0.98 to 4.17 ± 0.40, p = 0.003 for laxity. In men there is a decrease in the symptoms of urine loss and bladder filling p = 0.001. Three cases of vaginal rejuvenation are presented, the Female Sexual Function Index goes from an average of 3.2 to 4.9 (p = 0.002)

Our studies in development have shown an excellent improvement, Treatment improves pain and patient satisfaction and very good acceptance .Current evidence indicates that RF devices can improve vaginal laxity, increase sexual sensation, and urogenital symptoms of menopause. At this time, the safety profile of these devices is adequate and has been indicated by high rates of patient satisfaction.

Patients are satisfied or very satisfied with the innovative treatment that has improved their quality of life.

Pinheiro C, Alencar T, Amorim R, Campos R,  Brim R, Alcina Teles, Queiroz A, Lordelo P. .-    Intravaginal Non-Ablative Radiofrequency In The Treatment Of Genitourinary Syndrome Of Menopause symptoms: A Phase I Clinical Trial  DOI: 10.21203/rs.3.rs-244088/v1
Lordêlo P, Robatto Dantas Leal M, Menezes Santos J, Aires Brasil C, Neves Pavie Cardoso MC,  Sartori M.  Radiofrequency in the female genital laxity – a pilot study. Revista Pesquisa em Fisioterapia. 2014 Ago;4(2):152-159
Photiou L, Lin MJ, Dubin DP, Lenskaya V, Khorasani H. Review of non-invasive vulvovaginal rejuvenation. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):716-726. doi: 10.1111/jdv.16066